Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	723.76	712.81	593.24	498.99	437.77	349.85
Other Revenue	-0.46	19.15	51.16	-	-	-
Revenue	723.31	731.97	644.4	498.99	437.77	349.85
Revenue Growth (YoY)	-0.03%	13.59%	29.14%	13.98%	25.13%	8.53%
Cost of Revenue	366.27	358.11	290.57	250.13	238.03	206.51
Gross Profit	357.04	373.86	353.82	248.86	199.74	143.34
Selling, General & Admin	126.42	94.52	80.39	66.59	67.12	62.86
Research & Development	80.67	73.91	73.74	74.77	60.93	67.23
Operating Expenses	207.09	168.44	154.13	141.36	128.05	130.09
Operating Income	149.94	205.42	199.69	107.5	71.69	13.25
Interest Expense	-33.28	-35.34	-33.06	-1.85	-0.89	-0.37
Interest & Investment Income	8.55	10.61	5.46	1.32	0.6	0.64
Earnings From Equity Investments	-	-0.57	-1.98	-1.18	-0.21	-
Other Non Operating Income (Expenses)	10.46	9.08	1.97	9.07	13.54	6.22
EBT Excluding Unusual Items	135.67	189.19	172.08	114.86	84.73	19.74
Asset Writedown	-	-	-2.7	-	-	-
Legal Settlements	-	-	-	-	1	-12.8
Other Unusual Items	-	-	-	-	-1.8	-2.3
Pretax Income	135.67	189.19	169.38	114.86	83.93	4.64
Income Tax Expense	24.04	29.67	31.83	23.48	20.63	3.54
Earnings From Continuing Operations	111.63	159.52	137.55	91.39	63.3	1.1
Minority Interest in Earnings	-	-	-	-	-1.19	0.31
Net Income	111.63	159.52	137.55	91.39	62.12	1.4
Net Income to Common	111.63	159.52	137.55	91.39	62.12	1.4
Net Income Growth	-29.22%	15.98%	50.51%	47.12%	4327.37%	-97.13%
Shares Outstanding (Basic)	47	48	48	49	48	47
Shares Outstanding (Diluted)	49	52	53	52	50	49
Shares Change (YoY)	-6.16%	-1.78%	1.09%	5.31%	1.34%	-1.57%
EPS (Basic)	2.36	3.29	2.85	1.88	1.30	0.03
EPS (Diluted)	2.27	3.06	2.60	1.74	1.25	0.03
EPS Growth	-24.59%	17.69%	49.43%	39.20%	4090.97%	-96.96%
Free Cash Flow	113.26	172.35	145.34	65.15	70.54	23.41
Free Cash Flow Per Share	2.30	3.31	2.74	1.24	1.42	0.48
Gross Margin	49.36%	51.08%	54.91%	49.87%	45.63%	40.97%
Operating Margin	20.73%	28.06%	30.99%	21.54%	16.38%	3.79%
Profit Margin	15.43%	21.79%	21.34%	18.31%	14.19%	0.40%
Free Cash Flow Margin	15.66%	23.54%	22.55%	13.06%	16.11%	6.69%
EBITDA	205.73	258.39	237.72	132.27	94.95	34.78
EBITDA Margin	28.44%	35.30%	36.89%	26.51%	21.69%	9.94%
D&A For EBITDA	55.79	52.97	38.04	24.77	23.27	21.53
EBIT	149.94	205.42	199.69	107.5	71.69	13.25
EBIT Margin	20.73%	28.06%	30.99%	21.54%	16.38%	3.79%
Effective Tax Rate	17.72%	15.68%	18.79%	20.44%	24.58%	76.34%
Revenue as Reported	723.31	731.97	644.4	498.99	437.77	-
Advertising Expenses	-	10.5	10.4	8.7	8.1	5.8

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q